Mobile, ALNCT05880537Now EnrollingIRB Ready

End-Stage Renal Disease Clinical Trial in Mobile, AL

Access cutting-edge end-stage renal disease treatment through this clinical trial at a research site in Mobile. Study-provided care at no cost to qualified participants.

Sponsored by LifeNet Health

Quick Self-Assessment

See if you qualify for this Mobile location

Preparing your pre-screening questions…

Expert Care in Mobile

Access end-stage renal disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related end-stage renal disease treatment provided free

Apply for This Mobile Location

Check if you qualify for this end-stage renal disease clinical trial in Mobile, AL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Mobile

    Convenient for AL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Mobile site if eligible
  4. 4Begin participation

About This End-Stage Renal Disease Study in Mobile

Post market registry to assess the safety and efficacy of a novel decellularized human femoral artery allograft (Nexeon AVX Decellularized Femoral Artery,

Sponsor: LifeNet Health

Who Can Participate

Inclusion Criteria

Be male or female, ≥18 years of age at the time of graft placement
Have a diagnosis of ESRD or renal dysfunction requiring hemodialysis
Subject requires dialysis access to start or maintain dialysis treatment and placement of an AV access graft is a viable access option.
Have the ability themselves, or through their legal guardian, to understand the requirements of the study, to provide written informed consent/assent as evidenced by signature on an informed consent form (ICF) approved by an institutional review board (IRB), and to agree to abide by the study restrictions and return to the site for the required assessments
Have provided written authorization for use and disclosure of protected health information

Exclusion Criteria

Be participating in a study of another investigational drug or device
Have a known sensitivity to any of the processing reagents utilized in the manufacture of this product such as antibiotics (Lincomycin, Polymyxin B, Ciprofloxacin, Meropenum, Gentamicin, or Vancomycin) and processing reagents (N-lauroyl sarcosine, Denarase and glycerol/glycerin)
Have a history or evidence of severe cardiac disease, myocardial infarction within 6 months, ventricular arrhythmias, or unstable angina requiring continuing treatment
Have a history or evidence of severe peripheral vascular disease in the upper extremities
Have the inability or be unable or unwilling to follow the study visit schedule
Have the presence of any condition that, in the opinion of the investigator, places the subject at undue risk or potentially jeopardizes the quality of the data to be generated

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Mobile?

Yes, this clinical trial (NCT05880537) has an active research site in Mobile, AL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

End-Stage Renal Disease Treatment Options in Mobile, AL

If you're searching for end-stage renal disease treatment options in Mobile, AL, this clinical trial (NCT05880537) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Mobile research site is actively enrolling participants for this clinical trial. You'll receive care from experienced end-stage renal disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all end-stage renal disease clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Mobile, AL

See all ankylosing spondylitis clinical trials recruiting in Mobile — not just this study.

Browse Ankylosing Spondylitis Trials in Mobile →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsChronic Kidney Disease TrialsAll Conditions →

Ready to Join in Mobile?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Mobile, AL